Free Trial

Oregon Public Employees Retirement Fund Buys 6,652 Shares of Teleflex Incorporated (NYSE:TFX)

Teleflex logo with Medical background

Oregon Public Employees Retirement Fund lifted its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 168.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,600 shares of the medical technology company's stock after purchasing an additional 6,652 shares during the quarter. Oregon Public Employees Retirement Fund's holdings in Teleflex were worth $1,465,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. IFP Advisors Inc boosted its stake in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after buying an additional 217 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Teleflex by 2.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 407,203 shares of the medical technology company's stock valued at $72,474,000 after buying an additional 8,525 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Teleflex by 47.0% in the 4th quarter. Victory Capital Management Inc. now owns 52,011 shares of the medical technology company's stock valued at $9,257,000 after buying an additional 16,641 shares in the last quarter. Proficio Capital Partners LLC acquired a new stake in Teleflex in the 4th quarter valued at $3,297,000. Finally, Verdence Capital Advisors LLC boosted its stake in Teleflex by 19.0% in the 4th quarter. Verdence Capital Advisors LLC now owns 1,930 shares of the medical technology company's stock valued at $344,000 after buying an additional 308 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Ratings Changes

Several brokerages recently commented on TFX. Wells Fargo & Company decreased their price target on Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, May 2nd. Morgan Stanley reduced their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Royal Bank Of Canada reduced their price objective on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research note on Friday, May 2nd. Truist Financial reduced their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research note on Monday, May 5th. Finally, Mizuho set a $155.00 price objective on Teleflex in a research note on Wednesday, April 16th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $164.63.

View Our Latest Report on TFX

Teleflex Trading Down 1.4%

Shares of TFX stock traded down $1.69 on Friday, reaching $119.90. 360,058 shares of the stock were exchanged, compared to its average volume of 632,376. The stock has a market cap of $5.30 billion, a PE ratio of 37.82, a P/E/G ratio of 1.88 and a beta of 1.08. Teleflex Incorporated has a one year low of $115.94 and a one year high of $249.91. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.28 and a quick ratio of 1.32. The stock has a 50 day moving average price of $123.14 and a 200 day moving average price of $145.56.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The company had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The firm's quarterly revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.21 earnings per share. Equities research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.13%. Teleflex's payout ratio is currently 42.90%.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Should You Invest $1,000 in Teleflex Right Now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines